Pier 88 Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $612K | Sell |
4,870
-3,680
| -43% | -$463K | 0.11% | 78 |
|
|
2025
Q1 | $946K | Buy |
8,550
+3,860
| +82% | +$427K | 0.18% | 57 |
|
|
2024
Q4 | $640K | Buy |
4,690
+1,600
| +52% | +$218K | 0.13% | 65 |
|
|
2024
Q3 | $356K | Sell |
3,090
-460
| -13% | -$53K | 0.08% | 81 |
|
|
2024
Q2 | $489K | Buy |
3,550
+2,100
| +145% | +$289K | 0.11% | 78 |
|
|
2024
Q1 | $200K | Buy |
+1,450
| New | +$200K | 0.05% | 90 |
|